Fig. 5: AIMS subtype evolution of sequenced samples.
From: Determinants of response to CDK4/6 inhibitors in the real-world setting
a Pie charts comparing breast cancer subtypes across tissue timepoints as predicted by Absolute Assignment of Breast Cancer Intrinsic Molecular Subtype (AIMS). b Sankey plot comparing breast cancer subtypes across tissue timepoints as predicted by AIMS. c Heatmap showing activation/suppression of genes in the PAM50 gene set. The AIMS predicted subtypes showed strong association with the gene expression programs of patients using this biomarker.
